News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GeneOhm Sciences, Inc. Additional Series C Funding From Wasatch Advisors; Series C Adds Additional World Class Healthcare Investor


10/19/2005 5:09:50 PM

SAN DIEGO--(BUSINESS WIRE)--May 24, 2005--GeneOhm Sciences, an emerging leader in molecular diagnostics, announced that the company closed follow-on Series C funding with Wasatch Advisors. Wasatch Advisors, investment adviser to institutional clients and a family of mutual funds, specializes in small cap growth investing. Wasatch focuses on small cap companies with business models that enable sustained growth and margins and makes a select few private company investments with an eye toward further investment potential after the company completes an initial public offering.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES